BioSpace News Archive

Sight Sciences, Inc today announced it will report financial results for the fourth quarter and full year ended December 31, 2022, after the market close on Monday, March 13, 2023.

Vir Biotechnology, Inc. today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2022.

MannKind Corporation (Nasdaq: MNKD) today reported financial results for the fourth quarter and full year ended December 31, 2022.

SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”) today announced that it has commenced an underwritten public offering of shares of its common stock and warrants to purchase shares of its common stock.

Eko, a digital health company applying artificial intelligence (AI) in the fight against heart and lung disease, today announced the launch of the SENSORA™ Cardiac Disease Detection Platform.

NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX) will report its financial results for the fourth quarter ended December 31, 2022 before market on Thursday, March 9, 2023.

Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (“Therma” or the “Company”), developer and partner in a range of leading edge, proprietary diagnostic and medical device technologies, is pleased to provide an update on its partnership with Inretio Inc. (“Inretio”), a leading Israeli medical device startup developing a novel clot removal device for use in treating ischemic stroke patients.

Eyedea Medical, a Baltimore-based medtech startup working to alleviate the burden of corneal blindness through innovative solutions in corneal transplantation and eye banking, has been awarded a $1,000,000 Phase II Small Business Innovation Research grant from the National Science Foundation.

Cartography Biosciences announced the appointment of Chester Wong as Vice President, Head of Business Development.

Todos Medical, Ltd., a comprehensive medical diagnostics and related solutions company, provided a corporate update for shareholders.